Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts

Clinical Cancer Research

Volumn 8, Issue 12, 2002, Pages 3904-3909

  Pratesi, Graziella ^a   De Cesare, Michelandrea ^a   Carenini, Nives ^a   Perego, Paola ^a   Righetti, Sabina C ^a   Cucco, Carla ^c   Merlini, Lucio ^b   Pisano, Claudio ^c   Penco, Sergio ^c   Carminati, Paolo ^c   Vesci, Loredana ^c   Zunino, Franco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Sigma Tau SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CISPLATIN; GIMATECAN; TOPOTECAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MELANOMA; MOUSE; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PRIORITY JOURNAL; TUMOR REGRESSION; TUMOR XENOGRAFT;

EID: 0036898629     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Takimoto, C. H., Wright, J., and Arbuck, S. G. Clinical applications of the camptothecins. Biochim. Biophys. Acta, 1400: 107-119, 1998.
2. Burke, T. G. Chemistry of the camptothecins in the bloodstream. Drug stabilization and optimization of activity. Ann. N. Y. Acad. Sci., 803: 29-31, 1996.
3. Dallavalle, S., Delsoldato, T., Ferrari, A., Merlini, L., Penco, S., Carenini, N., Perego, P., De Cesare, M., Pratesi, G., and Zunino, F. Novel 7-substituted camptothecins with potent antitumor activity. J. Med. Chem., 43: 3963-3969, 2000.
4. Dallavalle, S., Ferrari, A., Biasotti, B., Merlini, L., Penco, S., Gallo, G., Marzi, M., Tinti, M. O., Martinelli, R., Pisano, C., Carminati, P., Carenini, N., Beretta, G., Perego, P., De Cesare, M., Pratesi, G., and Zunino, F. Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity. J. Med. Chem., 44: 3264-3274, 2001.
5. De Cesare, M., Pratesi, G., Perego, P., Carenini, N., Tinelli, S., Merlini, L., Penco, S., Pisano, C., Bucci, F., Vesci, L., Pace, S., Capocasa, F., Carminati, P., and Zunino, F. Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin. Cancer Res., 61: 7189-7195, 2001.
6. Perego, P., De Cesare, M., De Isabella, P., Carenini, N., Beggiolin, G., Pezzoni, G., Palumbo, M., Tartaglia, L., Pratesi, G., Pisano, C., Carminati, P., Scheffer, G. L., and Zunino, F. A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line. Cancer Res., 61: 6034-6037, 2001.
7. Perego, P., Giarola, M., Righetti, S. C., Supino, R., Caserini, C., Delia, D., Pierotti, M. A., Miyashita, T., Reed, J. C., and Zunino, F. Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell systems. Cancer Res., 56: 556-562, 1996.
8. Perego, P., Righetti, S. C., Supino, R., Delia, D., Caserini, C., Carenini, N., Bedognè, B., Broome, E., Krajewski, S., Reed, J. C., and Zunino, F. Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines. Apoptosis, 2: 540-548, 1997.
9. Ciusani, E., Perego, P., Carenini, N., Corna, E., Facchinetti, F., Boiardi, A., Salmaggi, A., and Zunino, F. Fas/CD95-mediated apoptosis in human glioblastoma cells: A target for sensitization to topoisomerase I inhibitors. Biochem. Pharmacol., 7027: 1-7, 2002.
10. Weller, M., Rieger, J., Grimmel, C., Van Meir, E. G., De Tribolet, N., Krajewski, S., Reed, J. C., von Deimling, A., and Dichgans, J. Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses. Int. J. Cancer, 79: 640-644, 1998.
11. Workman, P., Twentyman, P., Balkwill, F., Balmain, A., Chaplin, D., Double, J., Embleton, J., Newell, D., Raymond, R., Stables, J., Stephens, T., and Wallace, J. United Kingdom Co-ordinating Committee on Cancer Res. (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (ed. 2). Br. J. Cancer, 77: 1-10, 1998.
12. Pratesi, G., Manzotti, C., Tortoreto, M., Prosperi, E., and Zunino, F. Effects of 5-FU and cis-DDP combination on human colorectal tumor xenografts. Tumori, 75: 60-65, 1989.
13. Thompson, J., Stewart, C. F., and Houghton, P. J. Animal models for studying the action of topoisomerase I targeted drugs. Biochim. Biophys. Acta, 1400: 301-319, 1998.
14. Pommier, Y., Gupta, M., Valenti, M., and Nieves Neira, W. Cellular resistance to camptothecins. Ann. N. Y. Acad. Sci., 803: 60-73, 1996.
15. 2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function. J. Biol. Chem., 277: 1599-1606, 2002.
16. Perego, P., Boiardi, A., Carenini, N., De Cesare, M., Dolfini, E., Giardini, R., Magnani, I., Martignone, S., Silvani, A., Soranzo, C., and Zunino, F. Characterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs. J. Cancer Res. Clin. Oncol., 120: 585-592, 1994.
17. Houghton, P. J., Cheshire, P. J., Hallman, J. D., Lutz, L., Friedman, H. S., Danks, M. K., and Houghton, J. A. Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors. Cancer Chemother. Pharmacol., 36: 393-403, 1995.
18. Vassal, G., Boland, I., Santos, A., Bissery, M-C., Terrier-Lacombe, M-J., Morizet, J., Sainte-Rose, C., Lellouch-Tubiana, A., Kalifa, C., and Gouyette, A. Potent therapeutic activity of irinotecan (CPT-11) and its schedule dependency in medulloblastoma xenografts in nude mice. Int. J. Cancer, 73: 156-163, 1997.
19. Hare, C. B., Elion, G. B., Houghton, P. J., Houghton, J. A., Keir, S., Marcelli, S. L., Bigner, D. D., and Friedman, H. S. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother. Pharmacol., 39: 187-191, 1997.
20. Jansen, W. J., Kolfschoten, G. M., Erkelens, C. A., Van Ark-Otte, J., Pinedo, H. M., and Boven, E. Anti-tumor activity of CPT-11 in experimental human ovarian cancer and human soft-tissue sarcoma. Int. J. Cancer, 73: 891-896, 1997.